Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Rahmel

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Scientific Reports|March 29, 2023
Mortality rates of severe COVID-19-related respiratory failure with and without extracorporeal membrane oxygenation in the Middle Ruhr Region of GermanyAssem Aweimer, Lea Petschulat, Birger Jettkant, et al.
Infection|June 19, 2024
Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 Sepsis CohortAndrea Witowski, Lars Palmowski, Tim Rahmel, et al.
Critical Care (London, England)|July 7, 2022
Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort studyTim Rahmel, Felix Kraft, Helge Haberl, et al.
Ebiomedicine|December 16, 2024
Mortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohortLars Palmowski, Maike Weber, Malte Bayer, et al.
BMC Anesthesiology|January 6, 2022
The impact of the COVID-19 pandemic on non-COVID induced sepsis survivalMatthias Unterberg, Tim Rahmel, Katharina Rump, et al.
Infection|August 28, 2025
Machine learning identifies clinical sepsis phenotypes that translate to the plasma proteomeThilo Bracht, Maike Weber, Kerstin Kappler, et al.
BMC Geriatrics|July 15, 2018
Clinical Frailty Scale (CFS) reliably stratifies octogenarians in German ICUs: a multicentre prospective cohort studyJohanna M Muessig, Amir M Nia, Maryna Masyuk, et al.
Frontiers in Immunology|June 3, 2025
The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19Britta Westhus, Patrick Thon, Lars Palmowski, et al.
Frontiers in Immunology|October 31, 2022
Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, et al.
Frontiers in Immunology|November 20, 2025
AIMing for survival: The impact of the free and total AIM concentration in septic patientsBirte Dyck, Ulrich Bosch Dos Santos, Corinna Müller, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Scientific Reports|March 29, 2023
Mortality rates of severe COVID-19-related respiratory failure with and without extracorporeal membrane oxygenation in the Middle Ruhr Region of GermanyAssem Aweimer, Lea Petschulat, Birger Jettkant, et al.
Infection|June 19, 2024
Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 Sepsis CohortAndrea Witowski, Lars Palmowski, Tim Rahmel, et al.
Critical Care (London, England)|July 7, 2022
Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort studyTim Rahmel, Felix Kraft, Helge Haberl, et al.
Ebiomedicine|December 16, 2024
Mortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohortLars Palmowski, Maike Weber, Malte Bayer, et al.
BMC Anesthesiology|January 6, 2022
The impact of the COVID-19 pandemic on non-COVID induced sepsis survivalMatthias Unterberg, Tim Rahmel, Katharina Rump, et al.
Infection|August 28, 2025
Machine learning identifies clinical sepsis phenotypes that translate to the plasma proteomeThilo Bracht, Maike Weber, Kerstin Kappler, et al.
BMC Geriatrics|July 15, 2018
Clinical Frailty Scale (CFS) reliably stratifies octogenarians in German ICUs: a multicentre prospective cohort studyJohanna M Muessig, Amir M Nia, Maryna Masyuk, et al.
Frontiers in Immunology|June 3, 2025
The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19Britta Westhus, Patrick Thon, Lars Palmowski, et al.
Frontiers in Immunology|October 31, 2022
Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, et al.
Frontiers in Immunology|November 20, 2025
AIMing for survival: The impact of the free and total AIM concentration in septic patientsBirte Dyck, Ulrich Bosch Dos Santos, Corinna Müller, et al.
Pageof 8